Hexagon Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100
| Closed | -$8.3K | – | 1520 |
|
|
2022
Q4 | $8.3K | Sell |
100
-9
| -8% | -$747 | ﹤0.01% | 772 |
|
|
2022
Q3 | $9K | Buy |
109
+100
| +1,111% | +$8.26K | ﹤0.01% | 813 |
|
|
2022
Q2 | $1K | Buy |
9
+2
| +29% | +$222 | ﹤0.01% | 1147 |
|
|
2022
Q1 | $1K | Buy |
7
+6
| +600% | +$857 | ﹤0.01% | 901 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 905 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 890 |
|
|
2021
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 851 |
|